| Nitrite therapy after cardiac arrest reduces reactive oxygen species generation, improves cardiac and neurological function, and enhances survival via reversible inhibition of mitochondrial complex I. | |
| | |
MedLine Citation:
|
PMID: 19704094 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Three-fourths of cardiac arrest survivors die before hospital discharge or suffer significant neurological injury. Except for therapeutic hypothermia and revascularization, no novel therapies have been developed that improve survival or cardiac and neurological function after resuscitation. Nitrite (NO(2)(-)) increases cellular resilience to focal ischemia/reperfusion injury in multiple organs. We hypothesized that nitrite therapy may improve outcomes after the unique global ischemia/reperfusion insult of cardiopulmonary arrest. METHODS AND RESULTS: We developed a mouse model of cardiac arrest characterized by 12 minutes of normothermic asystole and a high cardiopulmonary resuscitation rate. In this model, global ischemia and cardiopulmonary resuscitation were associated with blood and organ nitrite depletion, reversible myocardial dysfunction, impaired alveolar gas exchange, neurological injury, and an approximately 50% mortality. A single low dose of intravenous nitrite (50 nmol=1.85 micromol/kg=0.13 mg/kg) compared with blinded saline placebo given at cardiopulmonary resuscitation initiation with epinephrine improved cardiac function, survival, and neurological outcomes. From a mechanistic standpoint, nitrite treatment restored intracardiac nitrite and increased S-nitrosothiol levels, decreased pathological cardiac mitochondrial oxygen consumption resulting from reactive oxygen species formation, and prevented oxidative enzymatic injury via reversible specific inhibition of respiratory chain complex I. CONCLUSIONS: Nitrite therapy after resuscitation from 12 minutes of asystole rapidly and reversibly modulated mitochondrial reactive oxygen species generation during early reperfusion, limiting acute cardiac dysfunction, death, and neurological impairment in survivors. |
| | |
Authors:
|
Cameron Dezfulian; Sruti Shiva; Aleksey Alekseyenko; Akshay Pendyal; D G Beiser; Jeeva P Munasinghe; Stasia A Anderson; Christopher F Chesley; T L Vanden Hoek; Mark T Gladwin |
Related Documents
:
|
10488934 - Resuscitation in europe: a tale of five european regions. 19762764 - Lipid emulsion improves recovery from bupivacaine-induced cardiac arrest, but not from ... 16982124 - Monitoring intervention programmes for out-of-hospital cardiac arrest in a mixed urban ... 11745264 - Characteristics of cardiac arrest in cancer patients as a predictor of survival after c... 12221414 - Quantitative analysis of aortic regurgitation: real-time 3-dimensional and 2-dimensiona... 20050864 - Second lineage of heart forming region provides new understanding of conotruncal heart ... |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't Date: 2009-08-24 |
Journal Detail:
|
Title: Circulation Volume: 120 ISSN: 1524-4539 ISO Abbreviation: Circulation Publication Date: 2009 Sep |
Date Detail:
|
Created Date: 2009-09-09 Completed Date: 2009-10-07 Revised Date: 2010-09-13 |
Medline Journal Info:
|
Nlm Unique ID: 0147763 Medline TA: Circulation Country: United States |
Other Details:
|
Languages: eng Pagination: 897-905 Citation Subset: AIM; IM |
Affiliation:
|
Pulmonary and Critical Care Medicine, Department of Medicine, and Cerebral Vascular Disease Research Center, Department of Neurology, University of Miami Miller School of Medicine, Miami, FL 33136, USA. cdezfulian@med.miami.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Cardiopulmonary Resuscitation* Electron Transport Complex I / antagonists & inhibitors* Heart / drug effects, physiopathology* Heart Arrest / metabolism, physiopathology*, therapy Injections, Intravenous Male Mice Mice, Inbred C57BL Nervous System / drug effects, physiopathology* Reactive Oxygen Species / antagonists & inhibitors* Sodium Nitrite / administration & dosage*, metabolism Survival Rate Time Factors |
| Grant Support | |
ID/Acronym/Agency:
|
Z01 HL005111-03/HL/NHLBI NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Reactive Oxygen Species; 7632-00-0/Sodium Nitrite; EC 1.6.5.3/Electron Transport Complex I |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Noninvasive coronary angiography by 320-row computed tomography with lower radiation exposure and ma...
Next Document: Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous...